Back
Aclaris Therapeutics Vs. John Wiley & Sons Industry Stock Comparison
Buy
51
ACRS
Aclaris Therapeutics
Last Price:
1.17
Seasonality Move:
-1.7%
Sell
43
WLY
John Wiley & Sons
Last Price:
48.06
Seasonality Move:
2.42%
Buy
51
Aclaris Therapeutics (ACRS)
is a Buy
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.17. The Score for ACRS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ACRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
John Wiley & Sons (WLY)
is a Sell
Is John Wiley & Sons a Buy, Sell or Hold?
- The current John Wiley & Sons [WLY] share price is $47.13. The Score for WLY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- WLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.17
The current trend is relatively stagnant and ACRS is experiencing buying pressure, which is a positive indicator for future bullish movement.
WLY Stock Price Chart
What is John Wiley & Sons's stock price today?
-
The John Wiley & Sons share price today is $47.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 48.14 | Sell |
| Chaikin Money Flow: | 211603 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.16 - 1.2) | Sell |
| Bollinger Bands (100): | (1.11 - 1.29) | Sell |
WLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.66 | Buy |
| Chaikin Money Flow: | 223333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.61 - 47.69) | Buy |
| Bollinger Bands (100): | (38.86 - 47) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Buy |
| 20-day SMA: | 1.17 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 1.16 | Buy |
| 20-day EMA: | 1.18 | Sell |
| 50-day EMA: | 1.2 | Sell |
| 200-day EMA: | 2.05 | Sell |
WLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.61 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 46.08 | Buy |
| 200-day SMA: | 38.92 | Buy |
| 8-day EMA: | 46.47 | Buy |
| 20-day EMA: | 46.14 | Buy |
| 50-day EMA: | 45.34 | Buy |
| 200-day EMA: | 40.76 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.13 per share, an increase this year of $1.08 per share, and a decrease next year of $0.09 per share.
John Wiley & Sons Earnings Growth & WLY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $0.26 per share.
Aclaris Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
John Wiley & Sons Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||